Optimal Timing for Hepatitis C Antiviral Therapy in the Peritransplant Period?

Hepatology - United States
doi 10.1002/hep.29300
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Peritransplant Antiviral Treatment of Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients

Liver Transplantation
HepatologyTransplantationSurgery
2018English

Recent Advances in Antiviral Therapy for Chronic Hepatitis C

Mediators of Inflammation
ImmunologyCell Biology
2016English

Oral Direct-Acting Antiviral Therapy for Hepatitis C

Journal of Antivirals & Antiretrovirals
2012English

Hepatitis C Virus Resistance to Antiviral Therapy

Hepatology
MedicineHepatology
2000English

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Digestive Diseases and Sciences
PhysiologyGastroenterology
2011English

Unmet Needs of Chronic Hepatitis C in the Era of Directacting Antiviral Therapy

Clinical and molecular hepatology
MedicineHepatologyMolecular Biology
2020English

Oscillations in Serum Ferritin Associated With Antiviral Therapy in Chronic Hepatitis C

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2009English

The Effect of Antiviral Therapy on Lipid Metabolism in Patients With Viral Hepatitis C

Revista de Chimie
SurfacesMaterials ScienceEngineeringMaterials ChemistryFilmsCoatingsChemistry
2018English

Longitudinal Liver Stiffness Assessment in Patients With Chronic Hepatitis C Undergoing Antiviral Therapy

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy